Patent Assignment
Reel/Frame 056608/0740
Assignment of Assignor's Interest
Recorded: 2021-06-21
Pages: 3
Assignee
MARINUS PHARMACEUTICALS, INC.
5 RADNOR CORPORATE CENTER, SUITE 500, 100 MATSONFORD ROAD, RADNOR, PENNSYLVANIA, 19087
Covered Property
(1)
Method of Treatment Using Nanoparticulate Ganaxolone Formulations
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
May 11, 2021
From: MARINUS PHARMACEUTICALS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 056206/0266 →
Security Interest
Oct 28, 2022
From: MARINUS PHARMACEUTICALS, INC.
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP
Reel/Frame 061580/0171 →
Release of Security Interest
Feb 13, 2025
From: SAGARD HEALTHCARE PARTNERS FUNDING COMPANY SPE 1, LLC
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 070204/0035 →
Release of Security Interest
Feb 20, 2025
From: OAKTREE FUND ADMINISTRATION, LLC
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 070278/0496 →
Change of Name
May 15, 2025
From: MARINUS PHARMACEUTICALS, INC.
To: IMMEDICA PHARMA US INC.
Reel/Frame 071128/0703 →